BioSpace

Stoffels strikes up new biotech in return to Galapagos cell therapy mission

A new biotech co-founded by Paul Stoffels has formed to take on the CAR T cell assets of Galapagos almost a year after the company—now known as Lakefront Biotherapeutics—abandoned them.

By BioSpace

1 min read
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights